Axillary recurrence rates were 1% for triple-negative BC, 2.8% for HER2-positive BC, 0.4% for luminal A BC, 0.9% for HER2-negative luminal B BC, and 0.5% for HER2-positive luminal B BC. The gene discussed is ERBB2; the disease is breast cancer.